AbCellera Biologics Inc. (ABCL) NASDAQ

$10.97 -0.21 (-1.88%)

Market Cap: $3.20B

As of 02/06/23 04:00 PM EST. Market closed.

(ABCL)

AbCellera Biologics Inc. (ABCL) NASDAQ

$10.97 -0.21 (-1.88%)

Market Cap: $3.20B

As of 02/06/23 04:00 PM EST. Market closed.

AbCellera is a technology company that searches, decodes, and analyzes natural immune systems to find antibodies that its partners can develop into drugs to prevent and treat disease. AbCellera partners with drug developers of all sizes, from large pharmaceutical to small biotechnology companies, empowering them to move quickly, reduce cost, and tackle the toughest problems in drug ... read more

AbCellera is a technology company that searches, decodes, and analyzes natural immune systems to find antibodies that its partners can develop into drugs to prevent and treat disease. AbCellera partners with drug developers of all sizes, from large pharmaceutical to small biotechnology companies, empowering them to move quickly, reduce cost, and tackle the toughest problems in drug development. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Carl L.G. Hansen
Full Time Employees
386
URL
Address
2215 Yukon Street, BC, Vancouver, V5Y 0A1.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Carl L.G. Hansen
Full Time Employees
386
Address
2215 Yukon Street, BC, Vancouver, V5Y 0A1.
PRICE CHART
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
KEY STATS
Open
$11.18
Previous Close
$11.18
Days Range
$10.94 - $11.29
52 week range
$5.42 - $14.97
Volume
1,139,083
Avg. Volume (30 days)
1,517,270
Market Cap
$3.20B
Dividend Yield
0.00%
P/E
-
Shares Outstanding
286,100,427
Open
$11.18
Previous Close
$11.18
Days Range
$10.94 - $11.29
52 week range
$5.42 - $14.97
Volume
1,139,083
Avg. Volume (30 days)
1,517,270
Market Cap
$3.20B
Dividend Yield
0.00%
P/E
-
Shares Outstanding
286,100,427

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR ABCELLERA BIOLOGICS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Booth AndrewChief Financial OfficerDec 20, 2022 Option Exercise$0.1950,0009,500188,500Dec 22, 2022, 02:31 PM
Thermopylae Holdings Ltd.10% OwnerDec 16, 2022 Buy$10.1085,102859,24955,859,493Dec 20, 2022, 10:18 AM
Hansen Carl L. G.Chief Executive OfficerNov 18, 2022 Option Exercise$2.7056,125151,538449,000Nov 21, 2022, 09:36 PM
Thermopylae Holdings Ltd.10% OwnerAug 19, 2022 Buy$11.46200,0002,292,46055,844,391Aug 22, 2022, 03:27 PM
Hansen Carl L. G.Chief Executive OfficerAug 18, 2022 Option Exercise$2.7056,125151,538392,875Aug 22, 2022, 03:09 PM
Thermopylae Holdings Ltd.10% OwnerJun 14, 2022 Buy$8.059,17373,84255,644,391Jun 15, 2022, 01:14 PM
Thermopylae Holdings Ltd.10% OwnerJun 13, 2022 Buy$8.0354,915441,06655,635,218Jun 15, 2022, 01:14 PM
Thermopylae Holdings Ltd.10% OwnerJun 06, 2022 Buy$7.5064,545483,96555,580,303Jun 08, 2022, 03:32 PM
Hansen Carl L. G.Chief Executive OfficerMay 18, 2022 Option Exercise$2.7056,125151,538336,750May 19, 2022, 01:17 PM
Lecault VeroniqueChief Operating OfficerMay 16, 2022 Buy$6.34200,0001,267,7801,770,122May 17, 2022, 03:07 PM
Thermopylae Holdings Ltd.10% OwnerMay 13, 2022 Buy$7.26300,0002,176,53055,515,758May 17, 2022, 03:04 PM
Thermopylae Holdings Ltd.10% OwnerMay 12, 2022 Buy$6.411,408,4689,021,80155,215,758May 16, 2022, 02:14 PM
Booth AndrewChief Financial OfficerMay 12, 2022 Buy$5.7985,000492,150138,500May 16, 2022, 02:13 PM
Montalbano John S.DirectorMar 04, 2022 Buy$8.5410,00085,40056,000Mar 04, 2022, 04:51 PM
Montalbano John S.DirectorMar 01, 2022 Buy$9.0520,000181,00046,000Mar 03, 2022, 12:06 PM
Lecault VeroniqueChief Operating OfficerFeb 28, 2022 Buy$8.66230,7891,998,6331,570,122Mar 01, 2022, 07:49 PM
Hansen Carl L. G.Chief Executive OfficerFeb 22, 2022 Option Exercise$2.7056,125151,538280,625Feb 25, 2022, 01:50 PM
Booth AndrewChief Financial OfficerDec 10, 2021 Option Exercise$0.32500,000160,000553,500Dec 10, 2021, 05:00 PM
Lecault VeroniqueChief Operating OfficerDec 08, 2021 Option Exercise$0.19250,00047,5001,589,333Dec 09, 2021, 05:49 PM
Lo AndrewDirectorDec 03, 2021 Buy$14.0286,9381,218,87186,938Dec 07, 2021, 03:17 PM
Lecault VeroniqueChief Operating OfficerNov 30, 2021 Option Exercise$0.1983,33315,8331,422,666Dec 03, 2021, 05:47 PM
Lecault VeroniqueChief Operating OfficerNov 30, 2021 Option Exercise$14.9683,3331,246,6621,422,666Dec 02, 2021, 02:16 PM
Hansen Carl L. G.Chief Executive OfficerNov 18, 2021 Option Exercise$15.03224,5003,374,235224,500Nov 22, 2021, 05:03 PM
Booth AndrewChief Financial OfficerNov 11, 2021 Buy$14.6114,000204,540130,959Nov 15, 2021, 06:05 AM
Booth AndrewChief Financial OfficerNov 11, 2021 Buy$14.7453,500788,59053,500Nov 15, 2021, 06:05 AM
Thermopylae Holdings Ltd.10% OwnerNov 11, 2021 Buy$14.76202,9602,995,91355,807,290Nov 15, 2021, 06:05 AM
Hayden Michael RDirectorSep 13, 2021 Option Exercise$17.73270,0004,787,1001,273,397Sep 15, 2021, 04:12 PM
Falconer EsterChief Technology OfficerSep 01, 2021 Option Exercise$16.89875,00014,778,749875,000Sep 03, 2021, 04:18 PM
HAMER JOHNDirectorSep 01, 2021 Sale$16.93137,3512,325,352128,862Sep 02, 2021, 06:12 PM
HAMER JOHNDirectorAug 31, 2021 Sale$16.95162,6492,756,901266,213Sep 02, 2021, 06:12 PM
Montalbano John S.DirectorAug 16, 2021 Buy$17.236,000103,38026,000Aug 17, 2021, 05:47 PM
Hayden Michael RDirectorJun 22, 2021 Sale$25.50100,0002,550,0001,003,397Jun 22, 2021, 06:50 PM
Thermopylae Holdings Ltd.10% OwnerJun 09, 2021 Sale$24.035,598,420134,530,03655,604,330Jun 10, 2021, 05:14 PM
Hansen Carl L. G.Chief Executive OfficerJun 09, 2021 Sale$24.136,000,000144,770,32655,604,330Jun 10, 2021, 05:11 PM
Lecault VeroniqueChief Operating OfficerJun 09, 2021 Sale$25.501,000,00025,500,000273,630Jun 10, 2021, 05:01 PM
Stimart TrynChief Legal OfficerJun 09, 2021 Sale$25.501,000,00025,500,000250Jun 10, 2021, 05:01 PM
Falconer EsterChief Technology OfficerJun 09, 2021 Sale$25.501,000,00025,500,0000Jun 10, 2021, 05:00 PM
Stimart TrynChief Legal OfficerJun 07, 2021 Option Exercise$0.811,000,000815,0001,000,250Jun 09, 2021, 08:30 PM
Booth AndrewChief Financial OfficerJun 07, 2021 Option Exercise$0.251,200,000306,0001,200,000Jun 09, 2021, 08:30 PM
Falconer EsterChief Technology OfficerMar 19, 2021 Option Exercise$0.031,000,00034,3001,000,000Apr 23, 2021, 08:00 PM
THIEL PETERDirectorDec 15, 2020 Buy$20.003,000,00060,000,00010,179,880Dec 17, 2020, 08:38 PM
Montalbano John S.DirectorDec 15, 2020 Buy$20.005,000100,0005,000Dec 17, 2020, 08:30 PM
Montalbano John S.DirectorDec 15, 2020 Buy$20.0020,000400,00020,000Dec 17, 2020, 08:30 PM
Lecault VeroniqueChief Operating OfficerDec 15, 2020 Buy$20.0017,000340,00061,580Dec 17, 2020, 08:30 PM
Lecault VeroniqueChief Operating OfficerDec 15, 2020 Buy$20.006,000120,0001,006,000Dec 17, 2020, 08:30 PM
Hayden Michael RDirectorNov 06, 2020 Option Exercise$0.33270,00089,100985,750Dec 17, 2020, 08:30 PM
Hayden Michael RDirectorDec 15, 2020 Buy$20.0073,6651,473,300118,245Dec 17, 2020, 08:30 PM
Stimart TrynChief Legal OfficerDec 15, 2020 Buy$20.002505,000250Dec 17, 2020, 08:30 PM
Stimart TrynChief Legal OfficerDec 15, 2020 Buy$20.002505,000250Dec 17, 2020, 08:30 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Booth AndrewChief Financial Officer12/20/20229,500
Thermopylae Holdings Ltd.10% Owner12/16/2022859,249
Hansen Carl L. G.Chief Executive Officer11/18/2022151,538
Thermopylae Holdings Ltd.10% Owner08/19/20222,292,460
Hansen Carl L. G.Chief Executive Officer08/18/2022151,538
Thermopylae Holdings Ltd.10% Owner06/14/202273,842
Thermopylae Holdings Ltd.10% Owner06/13/2022441,066
Thermopylae Holdings Ltd.10% Owner06/06/2022483,965
Hansen Carl L. G.Chief Executive Officer05/18/2022151,538
Lecault VeroniqueChief Operating Officer05/16/20221,267,780
Thermopylae Holdings Ltd.10% Owner05/13/20222,176,530
Thermopylae Holdings Ltd.10% Owner05/12/20229,021,801
Booth AndrewChief Financial Officer05/12/2022492,150
Montalbano John S.Director03/04/202285,400
Montalbano John S.Director03/01/2022181,000
Lecault VeroniqueChief Operating Officer02/28/20221,998,633
Hansen Carl L. G.Chief Executive Officer02/22/2022151,538
Booth AndrewChief Financial Officer12/10/2021160,000
Lecault VeroniqueChief Operating Officer12/08/202147,500
Lo AndrewDirector12/03/20211,218,871
Lecault VeroniqueChief Operating Officer11/30/202115,833
Lecault VeroniqueChief Operating Officer11/30/20211,246,662
Hansen Carl L. G.Chief Executive Officer11/18/20213,374,235
Booth AndrewChief Financial Officer11/11/2021204,540
Booth AndrewChief Financial Officer11/11/2021788,590
Thermopylae Holdings Ltd.10% Owner11/11/20212,995,913
Hayden Michael RDirector09/13/20214,787,100
Falconer EsterChief Technology Officer09/01/202114,778,749
HAMER JOHNDirector09/01/20212,325,352
HAMER JOHNDirector08/31/20212,756,901
Montalbano John S.Director08/16/2021103,380
Hayden Michael RDirector06/22/20212,550,000
Thermopylae Holdings Ltd.10% Owner06/09/2021134,530,036
Hansen Carl L. G.Chief Executive Officer06/09/2021144,770,326
Lecault VeroniqueChief Operating Officer06/09/202125,500,000
Stimart TrynChief Legal Officer06/09/202125,500,000
Falconer EsterChief Technology Officer06/09/202125,500,000
Stimart TrynChief Legal Officer06/07/2021815,000
Booth AndrewChief Financial Officer06/07/2021306,000
Falconer EsterChief Technology Officer03/19/202134,300
THIEL PETERDirector12/15/202060,000,000
Montalbano John S.Director12/15/2020100,000
Montalbano John S.Director12/15/2020400,000
Lecault VeroniqueChief Operating Officer12/15/2020340,000
Lecault VeroniqueChief Operating Officer12/15/2020120,000
Hayden Michael RDirector11/06/202089,100
Hayden Michael RDirector12/15/20201,473,300
Stimart TrynChief Legal Officer12/15/20205,000
Stimart TrynChief Legal Officer12/15/20205,000
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
09/30/2022
09/30/2021
-2.83%
4Q
09/30/2022
06/30/2021
-2.29%
5Q

Period of Report: 09/30/2022

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2021
-2.83%
4Q
06/30/2021
-2.29%
5Q